Evidence map›Paper›PMID 23979601›Full record

ArticleMolecular and cellular biology2013

Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signaling.

Victoria A McGuire, Alexander Gray, Claire E Monk, Susana G Santos, Keunwook Lee, Anna Aubareda, Jonathan Crowe, Natalia Ronkina, Jessica Schwermann, Ian H Batty and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Shiga Toxins Produced by EnterohaemorrhagicJournal of microbiology and biotechnology · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Akt-2 Is a Potential Therapeutic Target for Disseminated Candidiasis.Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Victoria A McGuireDivision of Cell Signalling and Immunology.
Alexander Gray
Claire E Monk
Susana G Santos
Keunwook Lee
Anna Aubareda
Jonathan Crowe
Natalia Ronkina
Jessica Schwermann
Ian H Batty
Nick R Leslie
Jonathan L E Dean
Stephen J O'Keefe
Mark Boothby
Matthias Gaestel
J Simon C Arthur
MRC Protein Phosphorylation and Ubiquitylation Unit · GBMedizinische Hochschule Hannover · DEUniversity of Dundee · GBUniversity of Oxford · GBVanderbilt University · USMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

Roles of rictor in mTOR signaling, differentiation & immune memory via Akt & PKCR01HL106812 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOOTHBY, MARK R · 2011 to 2018
$3.1M
Arthritis Research UKMedical Research Council G0801865NHLBI NIH HHS R01 HL106812
6 · The paper itself

Abstract

The stimulation of Toll-like receptors (TLRs) on macrophages by pathogen-associated molecular patterns (PAMPs) results in the activation of intracellular signaling pathways that are required for initiating a host immune response. Both phosphatidylinositol 3-kinase (PI3K)-Akt and p38 mitogen-activated protein kinase (MAPK) signaling pathways are activated rapidly in response to TLR activation and are required to coordinate effective host responses to pathogen invasion. In this study, we analyzed the role of the p38-dependent kinases MK2/3 in the activation of Akt and show that lipopolysaccharide (LPS)-induced phosphorylation of Akt on Thr308 and Ser473 requires p38α and MK2/3. In cells treated with p38 inhibitors or an MK2/3 inhibitor, phosphorylation of Akt on Ser473 and Thr308 is reduced and Akt activity is inhibited. Furthermore, BMDMs deficient in MK2/3 display greatly reduced phosphorylation of Ser473 and Thr308 following TLR stimulation. However, MK2/3 do not directly phosphorylate Akt in macrophages but act upstream of PDK1 and mTORC2 to regulate Akt phosphorylation. Akt is recruited to phosphatidylinositol 3,4,5-trisphosphate (PIP3) in the membrane, where it is activated by PDK1 and mTORC2. Analysis of lipid levels in MK2/3-deficient bone marrow-derived macrophages (BMDMs) revealed a role for MK2/3 in regulating Akt activity by affecting availability of PIP3 at the membrane. These data describe a novel role for p38α-MK2/3 in regulating TLR-induced Akt activation in macrophages.

Indexed as

AnimalsCell LineEnzyme ActivationHeat-Shock ProteinsImidazolesIntracellular Signaling Peptides and ProteinsLipopolysaccharidesMacrophagesMAP-Kinase-Activated Kinase 2MiceMice, Inbred C57BLMice, TransgenicMitogen-Activated Protein Kinase 14Molecular ChaperonesNeoplasm ProteinsPhosphatidylinositol PhosphatesHeat-Shock ProteinsHsbp1 protein, mouseImidazolesIntracellular Signaling Peptides and ProteinsLipopolysaccharidesMAP-Kinase-Activated Kinase 2MAP-kinase-activated kinase 3Mitogen-Activated Protein Kinase 14Molecular ChaperonesNeoplasm Proteinsphosphatidylinositol 3-phosphatePhosphatidylinositol PhosphatesProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktPyridazinesPyridinesPyrimidinesSB 203580Toll-Like ReceptorsVX-745

Identifiers

PMID23979601
PMCPMC3811899
OpenAlexW2063777233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.